Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: NEOPLASTIC STEM CELLS - DRUG EFFECTS , 1970. Treffer: 15
2017
Mayr, C; Ocker, M; Ritter, M; Pichler, M; Neureiter, D; Kiesslich, T
Biliary tract cancer stem cells - translational options and challenges.
World J Gastroenterol. 2017; 23(14):2470-2482
Doi: 10.3748/wjg.v23.i14.2470
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2016
Fan, P; Zhang, Y; Liu, L; Zhao, Z; Yin, Y; Xiao, X; Bauer, N; Gladkich, J; Mattern, J; Gao, C; Schemmer, P; Gross, W; Herr, I
Continuous exposure of pancreatic cancer cells to dietary bioactive agents does not induce drug resistance unlike chemotherapy.
Cell Death Dis. 2016; 7(6):e2246-e2246
Doi: 10.1038/cddis.2016.157
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Mayr, C; Wagner, A; Loeffelberger, M; Bruckner, D; Jakab, M; Berr, F; Di Fazio, P; Ocker, M; Neureiter, D; Pichler, M; Kiesslich, T
The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells.
Oncotarget. 2016; 7(1):745-758
Doi: 10.18632/oncotarget.6378
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2015
Mayr, C; Wagner, A; Stoecklinger, A; Jakab, M; Illig, R; Berr, F; Pichler, M; Di Fazio, P; Ocker, M; Neureiter, D; Kiesslich, T
3-Deazaneplanocin A May Directly Target Putative Cancer Stem Cells in Biliary Tract Cancer.
Anticancer Res. 2015; 35(9):4697-4705
Web of Science
PubMed
2014
Liu, L; Salnikov, AV; Bauer, N; Aleksandrowicz, E; Labsch, S; Nwaeburu, C; Mattern, J; Gladkich, J; Schemmer, P; Werner, J; Herr, I
Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-κB downregulation.
Int J Cancer. 2014; 134(10):2489-2503
Doi: 10.1002/ijc.28583
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Ress, AL; Stiegelbauer, V; Schwarzenbacher, D; Deutsch, A; Perakis, S; Ling, H; Ivan, C; Calin, GA; Rinner, B; Gerger, A; Pichler, M
Spinophilin expression determines cellular growth, cancer stemness and 5-flourouracil resistance in colorectal cancer.
Oncotarget. 2014; 5(18):8492-8502
Doi: 10.18632/oncotarget.2329
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2013
Herr, I; Lozanovski, V; Houben, P; Schemmer, P; Büchler, MW
Sulforaphane and related mustard oils in focus of cancer prevention and therapy.
Wien Med Wochenschr. 2013; 163(3-4):80-88
Doi: 10.1007/s10354-012-0163-3
PubMed
FullText
FullText_MUG
2012
Rausch, V; Liu, L; Apel, A; Rettig, T; Gladkich, J; Labsch, S; Kallifatidis, G; Kaczorowski, A; Groth, A; Gross, W; Gebhard, MM; Schemmer, P; Werner, J; Salnikov, AV; Zentgraf, H; Büchler, MW; Herr, I
Autophagy mediates survival of pancreatic tumour-initiating cells in a hypoxic microenvironment.
J Pathol. 2012; 227(3):325-335
Doi: 10.1002/path.3994
Web of Science
PubMed
FullText
FullText_MUG
2010
Cipak, A; Mrakovcic, L; Ciz, M; Lojek, A; Mihaylova, B; Goshev, I; Jaganjac, M; Cindric, M; Sitic, S; Margaritoni, M; Waeg, G; Balic, M; Zarkovic, N
Growth suppression of human breast carcinoma stem cells by lipid peroxidation product 4-hydroxy-2-nonenal and hydroxyl radical-modified collagen.
Acta Biochim Pol. 2010; 57(2):165-171
Doi: 10.18388/abp.2010_2390
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Rausch, V; Liu, L; Kallifatidis, G; Baumann, B; Mattern, J; Gladkich, J; Wirth, T; Schemmer, P; Büchler, MW; Zöller, M; Salnikov, AV; Herr, I
Synergistic activity of sorafenib and sulforaphane abolishes pancreatic cancer stem cell characteristics.
Cancer Res. 2010; 70(12):5004-5013
Doi: 10.1158/0008-5472.CAN-10-0066
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Tomuleasa, C; Soritau, O; Rus-Ciuca, D; Pop, T; Todea, D; Mosteanu, O; Pintea, B; Foris, V; Susman, S; Kacsó, G; Irimie, A
Isolation and characterization of hepatic cancer cells with stem-like properties from hepatocellular carcinoma.
J Gastrointestin Liver Dis. 2010; 19(1):61-67
[OPEN ACCESS]
Web of Science
PubMed
2009
Gleixner, KV; Mayerhofer, M; Vales, A; Gruze, A; Hörmann, G; Cerny-Reiterer, S; Lackner, E; Hadzijusufovic, E; Herrmann, H; Iyer, AK; Krauth, MT; Pickl, WF; Marian, B; Panzer-Grümayer, R; Sillaber, C; Maeda, H; Zielinski, C; Valent, P
Targeting of hsp32 in solid tumors and leukemias: a novel approach to optimize anticancer therapy.
Curr Cancer Drug Targets. 2009; 9(5): 675-689.
Doi: 10.2174/156800909789057024
Web of Science
PubMed
FullText
FullText_MUG
2008
Houben, R; Wischhusen, J; Menaa, F; Synwoldt, P; Schrama, D; Brocker, EB; Becker, JC
Melanoma stem cells: targets for successful Therapy?
J DTSCH DERMATOL GES. 2008; 6(7): 541-547.
Doi: 10.1111/j.1610-0387.2008.06786.x
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Petru, E
Re: Chemotherapy-related myelosuppression as a marker for survival in epithelial ovarian cancer patients by Rocconi et al.
Gynecol Oncol. 2008; 111(1): 159-160.
Doi: 10.1016/j.ygyno.2008.06.005
Web of Science
PubMed
FullText
FullText_MUG
1999
Pfeilstöcker, M; Karlic, H; Paukovits, J; Anzenberger, G; Louda, N; Salamon, J; Mühlberger, H; Strobl, H; Pittermann, E; Heinz, R
In vivo and in vitro effects of cytokines and the hemoregulatory peptide dimer (pEEDCK)2 (pyroGlu-Glu-Asp-Cys-Lys)2 on G alpha16-positive hematopoiesis.
Leukemia. 1999; 13(4):590-594
Doi: 10.1038/sj.leu.2401377
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar